COGNITIVE BEHAVIORAL AND PHARMACOLOGICAL TREATMENT OF SOCIAL PHOBIA

社交恐惧症的认知行为和药物治疗

• 批准号: 6117024
• 负责人: RICHARD G HEIMBERG
• 金额: $ 5.92万
• 依托单位: TEMPLE UNIV OF THE COMMONWEALTH
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6117024
• 关键词: anxiety disorders; behavioral /social science research tag; clinical research; clinical trials; cognitive behavior therapy; group therapy; human subject; human therapy evaluation; mental disorder chemotherapy; phenelzine; phobias; social behavior disorders

The primary objective of this study is the continued evaluation of cognitive-behavioral group therapy and the monoamine oxidase inhibitor phenelzine as treatments for the anxiety disorder social phobia. In this study, we examine a number of additional questions, e g:(1)is there utility to combining cognitive behavioral therapy with phenelzine pharmacotherapy; (2) does cognitive behavioral treatment produce greater effects if administered for a longer period of time.

本研究的主要目的是继续评估认知行为团体疗法和单胺氧化酶抑制剂苯乙肼治疗焦虑症社交恐惧症。 在这项研究中，我们检查了一些额外的问题，例如：（1）是否有效用结合认知行为治疗与苯乙肼药物治疗;（2）是否认知行为治疗产生更大的影响，如果管理较长的时间。